Quick Answer
EXELIXIS, INC. reported Total Revenue of $2.32 billion for fiscal year 2025.
EXELIXIS, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.32B +7.0% |
$2.17B +18.5% |
$1.83B +13.6% |
$1.61B +12.3% |
$1.43B +45.3% |
$987.54M +2.0% |
| Revenue (ASC 606) | $2.32B +7.0% |
$2.17B +18.5% |
$1.83B +13.6% |
$1.61B +12.3% |
$1.43B +45.3% |
$987.54M +2.0% |
| Net Income | $782.57M +50.1% |
$521.27M +150.9% |
$207.76M +14.0% |
$182.28M -21.1% |
$231.06M +106.7% |
$111.78M -65.2% |
| Diluted EPS | $2.78 +58.0% |
$1.76 +170.8% |
$0.65 +16.1% |
$0.56 -22.2% |
$0.72 +105.7% |
$0.35 -65.7% |
| Total Assets | $2.84B -3.5% |
$2.95B +0.2% |
$2.94B -4.2% |
$3.07B +17.4% |
$2.62B +22.4% |
$2.14B +13.3% |
| Cash and Equivalents | $482.49M +122.0% |
$217.37M -17.3% |
$262.99M -47.5% |
$501.19M -22.6% |
$647.17M +102.7% |
$319.22M +19.8% |
| Stockholders Equity | $2.16B -3.7% |
$2.24B -0.9% |
$2.26B -9.0% |
$2.49B +12.6% |
$2.21B +17.6% |
$1.88B +11.5% |
| R&D Expense | $825.00M -9.4% |
$910.41M -12.8% |
$1.04B +17.1% |
$891.81M +28.6% |
$693.72M +26.6% |
$547.85M +62.6% |
| Operating Income | $872.19M +44.3% |
$604.62M +253.8% |
$170.88M -15.2% |
$201.48M -29.7% |
$286.67M +160.5% |
$110.06M -70.2% |
| Shares Outstanding | 262.48M -6.8% |
281.73M -7.0% |
302.79M -6.5% |
323.95M +1.6% |
318.84M +2.3% |
311.63M +2.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $597.75M | +10.8% | +5.2% |
| Revenue (ASC 606) | September 30, 2025 | $597.75M | +10.8% | +5.2% |
| Net Income | September 30, 2025 | $193.58M | +64.1% | +4.7% |
| Diluted EPS | September 30, 2025 | $0.69 | +72.5% | +6.2% |
| Total Assets | September 30, 2025 | $2.82B | -4.6% | +5.4% |
| Cash and Equivalents | September 30, 2025 | $376.30M | +45.7% | +128.8% |
| Stockholders Equity | September 30, 2025 | $2.16B | -5.0% | +6.3% |
| R&D Expense | September 30, 2025 | $199.16M | -10.5% | -0.6% |
| Operating Income | September 30, 2025 | $236.54M | +73.8% | +10.8% |
| Shares Outstanding | September 30, 2025 | 268.10M | -6.2% | -0.8% |
- EXELIXIS, INC. reported Total Revenue of $2.32 billion for fiscal year 2025.
- EXELIXIS, INC. showed an increase of +7.0% in Total Revenue compared to the prior fiscal year.
- EXELIXIS, INC. reported Revenue (ASC 606) of $2.32 billion for fiscal year 2025.
- EXELIXIS, INC. showed an increase of +7.0% in Revenue (ASC 606) compared to the prior fiscal year.
- EXELIXIS, INC. reported Net Income of $782.57 million for fiscal year 2025.
- EXELIXIS, INC. showed an increase of +50.1% in Net Income compared to the prior fiscal year.
- EXELIXIS, INC. reported Diluted EPS of $2.78 per share for fiscal year 2025.
- EXELIXIS, INC. showed an increase of +58.0% in Diluted EPS compared to the prior fiscal year.
- EXELIXIS, INC. reported Total Assets of $2.84 billion for fiscal year 2025.
- EXELIXIS, INC. showed a decrease of -3.5% in Total Assets compared to the prior fiscal year.
- EXELIXIS, INC. reported Cash and Equivalents of $482.49 million for fiscal year 2025.
- EXELIXIS, INC. showed an increase of +122.0% in Cash and Equivalents compared to the prior fiscal year.
- EXELIXIS, INC. reported Stockholders Equity of $2.16 billion for fiscal year 2025.
- EXELIXIS, INC. showed a decrease of -3.7% in Stockholders Equity compared to the prior fiscal year.
- EXELIXIS, INC. reported R&D Expense of $825.00 million for fiscal year 2025.
- EXELIXIS, INC. showed a decrease of -9.4% in R&D Expense compared to the prior fiscal year.
- EXELIXIS, INC. reported Operating Income of $872.19 million for fiscal year 2025.
- EXELIXIS, INC. showed an increase of +44.3% in Operating Income compared to the prior fiscal year.
- EXELIXIS, INC. reported Shares Outstanding of 262.48 million shares for fiscal year 2025.
- EXELIXIS, INC. showed a decrease of -6.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: